Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy-Reference-Cited by-同舟云学术

Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy

Published:2015-03-02 Issue:4 Volume:4 Page:e1008866
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Pol Jonathan,Vacchelli Erika,Aranda Fernando,Castoldi Francesca,Eggermont Alexander,Cremer Isabelle,Sautès-Fridman Catherine,Fucikova Jitka,Galon Jérôme,Spisek Radek,Tartour Eric,Zitvogel Laurence,Kroemer Guido,Galluzzi Lorenzo

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/2162402X.2015.1008866

Reference171 articles.

1. Immunogenic Cell Death in Cancer Therapy

2. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

3. Consensus guidelines for the detection of immunogenic cell death

4. Immunogenic cell death and DAMPs in cancer therapy

5. Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy

Cited by 247 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression, regulation, and function of PD-L1 on non-tumor cells in the tumor microenvironment;Drug Discovery Today;2024-09

2. Maximizing therapeutic outcomes in hepatocellular carcinoma: Insights into combinatorial strategies;World Journal of Gastrointestinal Oncology;2024-07-15

3. Shifting cold to hot tumors by nanoparticle-loaded drugs and products;Clinical and Translational Oncology;2024-06-26

4. Immunoregulatory cyclophilin a improves low-dose chemotherapy with a modulation of the immune tumor microenvironment in experimental models of melanoma B16 and lymphoma EL4 in vivo;Cancer Chemotherapy and Pharmacology;2024-06-24

5. Development of perioperative immune checkpoint inhibitor therapy for locally advanced esophageal squamous cell carcinoma;Future Oncology;2024-05-17